The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumInsights - Fate Therapeutics (FATE) reported additional data for their two off-the-shelf NK cell programs after market yesterday. This was an important event because it would read-through to NK … Continue Reading
PremiumInsights - Eloxx (ELOX) provided a Q2 business update earlier this week, and everything was on schedule. Based on enrollment at the end of June, the company remainson track to report … Continue Reading
PremiumInsights - Essa (EPIX) reported their Q2 business update this morning. The rumors were true – Phase 1 monotherapy data will be pushed from 2H 2021 to 1H 2022. … Continue Reading
PremiumInsights - Essa (EPIX) is down 50% in the last month, with really aggressive selling coming in the last 6 trading days. Since Thursday August 5th, Essa … Continue Reading
PremiumInsights - Novavax (NVAX) had their Q2 business update call yesterday after market. The company announced yet another delay in the US submission, while the rest of the world’s … Continue Reading
PremiumInsights - Jounce (JNCE) announced 2Q results today and the company is progressing well on their Phase 1 JTX-8064 (LILRB2 / ILT4) in solid tumors. Jounce completed enrollment of … Continue Reading
PremiumDigital Conferences - Transcript of Digital Conference Participants Fahar Merchant – President & Chief Executive Officer, Medicenna Mann Muhsin – Chief Medical Officer, Medicenna Elizabeth Williams – Chief … Continue Reading
Read now
